Bilateral Atypical Femur Fracture in a Patient Under Bisphosphonate Treatment

Osteoporosis is a systemic skeletal disease that affects most of the elderly people. Bisphosphonate is an effective anti-resorptive drug widely used for the prevention and treatment of osteoporosis. However, recent evidence has linked longterm bisphosphonate use with an atypical fracture. We report...

Full description

Saved in:
Bibliographic Details
Published in:Turkish journal of endocrinology and metabolism 2019, Vol.23 (3), p.187-190
Main Authors: ŞİLTE KARAMANLIOĞLU, Duygu, KAYSIN, Meryem, BİLGİN BADUR, Naciye, ÜNLÜ ÖZKAN, Feyza, AKTAŞ, İlknur
Format: Article
Language:English
Subjects:
Bisphosphonates
Fractures
Older people
Osteoporosis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Osteoporosis is a systemic skeletal disease that affects most of the elderly people. Bisphosphonate is an effective anti-resorptive drug widely used for the prevention and treatment of osteoporosis. However, recent evidence has linked longterm bisphosphonate use with an atypical fracture. We report a case of a 79-year-old woman who had been on bisphosphonate treatment for eight years and presented with bilateral femur diaphyseal fractures occurring within an interval of a few months. The physicians must consider the possibility of atypical fractures with the fresh onset of groin or mid-thigh pain in patients who have been on bisphosphonate therapy, particularly for more than five years.
ISSN:1301-2193
1308-9846
DOI:10.25179/tjem.2018-64415